GlassScriptPhysician profile
Kimberly A Cochran
NPI 1376508358
$492.62
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2021: $17.25.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $84.57 | 2019 | |
| Acadia Pharmaceuticals INC | $79.43 | 2019 | |
| Biogen, INC. | $45.41 | 2019 | |
| Adamas Pharmaceuticals, INC. | $43.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.01 | 2019 | |
| Genzyme Corporation | $31.75 | 2019 | |
| Lilly USA, LLC | $31.73 | 2019 | |
| Abbvie INC. | $17.25 | 2021 | |
| Livanova USA, INC. | $16.41 | 2019 | |
| Ucb, INC. | $15.51 | 2019 | |
| Grifols USA, LLC | $14.69 | 2019 | |
| Allergan, INC. | $14.69 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.50 | 2019 | |
| Promius Pharma LLC | $14.16 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.33 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $12.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Cochran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.